Trastuzumab Deruxtecan Decreases Risk Of Disease Progression And Death In HER2 Positive Breast Cancer: NEJM | Doctor News Daily

April 22, 2025

Get In Touch

contact@doctornewsdaily.com
Sky One, Pune, Maharashtra, 411006, India

Create an account to read this article

You need to create an account to read this article.

Create Account Sign in

Medicine Oncology

Trastuzumab Deruxtecan Decreases Risk Of Disease Progression And Death In HER2 Positive Breast Cancer: NEJM

byDoctor News Daily Team
18 February, 2025
0 Comments
0 Mins

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!